Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 83

1.

The Association of Olfactory Function with BMI, Appetite, and Prospective Weight Change in Dutch Community-Dwelling Older Adults.

Fluitman KS, Nadar HJ, Roos DS, Berendse HW, Keijser BJF, Nieuwdorp M, Ijzerman RG, Visser M.

J Nutr Health Aging. 2019;23(8):746-752. doi: 10.1007/s12603-019-1241-7.

2.

Erratum. SGLT2 Inhibitors in Combination Therapy: From Mechanisms to Clinical Considerations in Type 2 Diabetes Management. Diabetes Care 2018;41:1543-1556.

van Baar MJB, van Ruiten CC, Muskiet MHA, van Bloemendaal L, IJzerman RG, van Raalte DH.

Diabetes Care. 2019 Oct;42(10):2015. doi: 10.2337/dc19-er10a. Epub 2019 Aug 20. No abstract available.

3.

SUGAR-DIP trial: oral medication strategy versus insulin for diabetes in pregnancy, study protocol for a multicentre, open-label, non-inferiority, randomised controlled trial.

de Wit L, Rademaker D, Voormolen DN, Akerboom BMC, Kiewiet-Kemper RM, Soeters MR, Verwij-Didden MAL, Assouiki F, Schippers DH, Vermeulen MAR, Kuppens SMI, Oosterwerff MM, Zwart JJ, Diekman MJM, Vogelvang TE, Gallas PRJ, Galjaard S, Visser W, Horree N, Klooker TK, Laan R, Heijligenberg R, Huisjes AJM, van Bemmel T, van Meir CA, van den Beld AW, Hermes W, Vidarsdottir S, Veldhuis-Vlug AG, Dullemond RC, Jansen HJ, Sueters M, de Koning EJP, van Laar JOEH, Wouters-van Poppel P, Sanson-van Praag ME, van den Akker ES, Brouwer CB, Hermsen BB, Potter van Loon BJ, van der Heijden OWH, de Galan BE, van Leeuwen M, Wijbenga JAM, de Boer K, van Bon AC, van der Made FW, Eskes SA, Zandstra M, van Houtum WH, Braams-Lisman BAM, Daemen-Gubbels CRGM, Wouters MGAJ, IJzerman RG, Mensing van Charante NA, Zwertbroek R, Bosmans JE, Evers IM, Mol BW, de Valk HW, Groenendaal F, Naaktgeboren CA, Painter RC, deVries JH, Franx A, van Rijn BB.

BMJ Open. 2019 Aug 18;9(8):e029808. doi: 10.1136/bmjopen-2019-029808.

4.

GLP-1 receptor agonists do not affect sodium intake: Exploratory analyses from two randomized clinical trials.

Smits MM, Ten Kulve JS, van Bloemendaal L, Tonneijck L, Muskiet MHA, Kramer MHH, Ijzerman RG, van Raalte DH.

Nutrition. 2019 Nov - Dec;67-68:110524. doi: 10.1016/j.nut.2019.06.005. Epub 2019 Jun 14.

PMID:
31415908
5.

The presence of cerebral white matter lesions and lower skin microvascular perfusion predicts lower cognitive performance in type 1 diabetes patients with retinopathy but not in healthy controls-A longitudinal study.

Emanuel AL, van Duinkerken E, Wattjes MP, Klein M, Barkhof F, Snoek FJ, Diamant M, Eringa EC, IJzerman RG, Serné EH.

Microcirculation. 2019 Apr;26(3):e12530. doi: 10.1111/micc.12530. Epub 2019 Feb 22.

6.

SGLT2 Inhibitors in Combination Therapy: From Mechanisms to Clinical Considerations in Type 2 Diabetes Management.

van Baar MJB, van Ruiten CC, Muskiet MHA, van Bloemendaal L, IJzerman RG, van Raalte DH.

Diabetes Care. 2018 Aug;41(8):1543-1556. doi: 10.2337/dc18-0588. Review. Erratum in: Diabetes Care. 2019 Oct;42(10):2015.

PMID:
30030256
7.

Peripartum fetal distress in diabetic women: a retrospective case-cohort study.

Castelijn B, Hollander K, Hensbergen JF, IJzerman RG, Valkenburg-van den Berg AW, Twisk J, De Groot C, Wouters M.

BMC Pregnancy Childbirth. 2018 Jun 14;18(1):228. doi: 10.1186/s12884-018-1880-4.

8.

Metataxonomic Analysis of Individuals at BMI Extremes and Monozygotic Twins Discordant for BMI.

Finnicum CT, Doornweerd S, Dolan CV, Luningham JM, Beck JJ, Willemsen G, Ehli EA, Boomsma DI, Ijzerman RG, Davies GE, de Geus EJC.

Twin Res Hum Genet. 2018 Jun;21(3):203-213. doi: 10.1017/thg.2018.26.

PMID:
29792248
9.

Accelerated executive functions decline and gray matter structural changes in middle-aged type 1 diabetes mellitus patients with proliferative retinopathy.

van Duinkerken E, Steenwijk MD, Klein M, Barkhof F, Mograbi DC, Diamant M, Snoek FJ, Ijzerman RG.

J Diabetes. 2018 Nov;10(11):835-846. doi: 10.1111/1753-0407.12773. Epub 2018 May 30.

PMID:
29665283
10.

Cortical and subcortical gray matter structural alterations in normoglycemic obese and type 2 diabetes patients: relationship with adiposity, glucose, and insulin.

Bernardes G, IJzerman RG, Ten Kulve JS, Barkhof F, Diamant M, Veltman DJ, Landeira-Fernandez J, van Bloemendaal L, van Duinkerken E.

Metab Brain Dis. 2018 Aug;33(4):1211-1222. doi: 10.1007/s11011-018-0223-5. Epub 2018 Apr 13.

11.

Potential of butyrate to influence food intake in mice and men.

Fluitman KS, Wijdeveld M, Nieuwdorp M, IJzerman RG.

Gut. 2018 Jul;67(7):1203-1204. doi: 10.1136/gutjnl-2017-315543. Epub 2018 Jan 30. No abstract available.

12.

Elevated Postoperative Endogenous GLP-1 Levels Mediate Effects of Roux-en-Y Gastric Bypass on Neural Responsivity to Food Cues.

Ten Kulve JS, Veltman DJ, Gerdes VEA, van Bloemendaal L, Barkhof F, Deacon CF, Holst JJ, Drent ML, Diamant M, IJzerman RG.

Diabetes Care. 2017 Nov;40(11):1522-1529. doi: 10.2337/dc16-2113.

PMID:
29025878
13.

Overweight is associated with lower resting state functional connectivity in females after eliminating genetic effects: A twin study.

Doornweerd S, van Duinkerken E, de Geus EJ, Arbab-Zadeh P, Veltman DJ, IJzerman RG.

Hum Brain Mapp. 2017 Oct;38(10):5069-5081. doi: 10.1002/hbm.23715. Epub 2017 Jul 17.

PMID:
28718512
14.

Brain reward responses to food stimuli among female monozygotic twins discordant for BMI.

Doornweerd S, De Geus EJ, Barkhof F, Van Bloemendaal L, Boomsma DI, Van Dongen J, Drent ML, Willemsen G, Veltman DJ, IJzerman RG.

Brain Imaging Behav. 2018 Jun;12(3):718-727. doi: 10.1007/s11682-017-9711-1.

15.

The intestinal microbiota, energy balance, and malnutrition: emphasis on the role of short-chain fatty acids.

Fluitman KS, De Clercq NC, Keijser BJF, Visser M, Nieuwdorp M, IJzerman RG.

Expert Rev Endocrinol Metab. 2017 May;12(3):215-226. doi: 10.1080/17446651.2017.1318060. Epub 2017 Apr 26.

PMID:
30063458
16.

Altered eigenvector centrality is related to local resting-state network functional connectivity in patients with longstanding type 1 diabetes mellitus.

van Duinkerken E, Schoonheim MM, IJzerman RG, Moll AC, Landeira-Fernandez J, Klein M, Diamant M, Snoek FJ, Barkhof F, Wink AM.

Hum Brain Mapp. 2017 Jul;38(7):3623-3636. doi: 10.1002/hbm.23617. Epub 2017 Apr 21.

PMID:
28429383
17.

Emerging role of intestinal microbiota and microbial metabolites in metabolic control.

Herrema H, IJzerman RG, Nieuwdorp M.

Diabetologia. 2017 Apr;60(4):613-617. doi: 10.1007/s00125-016-4192-0. Epub 2016 Dec 24.

PMID:
28013341
18.

Subgenual Cingulate Cortex Functional Connectivity in Relation to Depressive Symptoms and Cognitive Functioning in Type 1 Diabetes Mellitus Patients.

van Duinkerken E, Ryan CM, Schoonheim MM, Barkhof F, Klein M, Moll AC, Diamant M, IJzerman RG, Snoek FJ.

Psychosom Med. 2016 Jul-Aug;78(6):740-9. doi: 10.1097/PSY.0000000000000335.

PMID:
27136504
19.

Physical activity and dietary intake in BMI discordant identical twins.

Doornweerd S, IJzerman RG, van der Eijk L, Neter JE, van Dongen J, van der Ploeg HP, de Geus EJ.

Obesity (Silver Spring). 2016 Jun;24(6):1349-55. doi: 10.1002/oby.21475. Epub 2016 Apr 23.

20.

Alterations in white matter volume and integrity in obesity and type 2 diabetes.

van Bloemendaal L, Ijzerman RG, Ten Kulve JS, Barkhof F, Diamant M, Veltman DJ, van Duinkerken E.

Metab Brain Dis. 2016 Jun;31(3):621-9. doi: 10.1007/s11011-016-9792-3. Epub 2016 Jan 27.

21.

Endogenous GLP1 and GLP1 analogue alter CNS responses to palatable food consumption.

Ten Kulve JS, Veltman DJ, van Bloemendaal L, Groot PF, Ruhé HG, Barkhof F, Diamant M, Ijzerman RG.

J Endocrinol. 2016 Apr;229(1):1-12. doi: 10.1530/JOE-15-0461. Epub 2016 Jan 14.

PMID:
26769912
22.

Disrupted subject-specific gray matter network properties and cognitive dysfunction in type 1 diabetes patients with and without proliferative retinopathy.

van Duinkerken E, Ijzerman RG, Klein M, Moll AC, Snoek FJ, Scheltens P, Pouwels PJ, Barkhof F, Diamant M, Tijms BM.

Hum Brain Mapp. 2016 Mar;37(3):1194-208. doi: 10.1002/hbm.23096. Epub 2015 Dec 23.

PMID:
26700243
23.

Decreased Hypothalamic Glucagon-Like Peptide-1 Receptor Expression in Type 2 Diabetes Patients.

Ten Kulve JS, van Bloemendaal L, Balesar R, IJzerman RG, Swaab DF, Diamant M, la Fleur SE, Alkemade A.

J Clin Endocrinol Metab. 2016 May;101(5):2122-9. doi: 10.1210/jc.2015-3291. Epub 2015 Dec 16.

PMID:
26672638
24.

Lower birth weight is associated with alterations in dietary intake in adolescents independent of genetic factors: A twin study.

Doornweerd S, IJzerman RG, Weijs PJ, Diamant M, de Geus EJ, Boomsma DI.

Clin Nutr. 2017 Feb;36(1):179-185. doi: 10.1016/j.clnu.2015.10.012. Epub 2015 Oct 30.

PMID:
26575849
25.

Endogenous GLP-1 mediates postprandial reductions in activation in central reward and satiety areas in patients with type 2 diabetes.

ten Kulve JS, Veltman DJ, van Bloemendaal L, Barkhof F, Deacon CF, Holst JJ, Konrad RJ, Sloan JH, Drent ML, Diamant M, IJzerman RG.

Diabetologia. 2015 Dec;58(12):2688-98. doi: 10.1007/s00125-015-3754-x. Epub 2015 Sep 18.

26.

Emotional eating is associated with increased brain responses to food-cues and reduced sensitivity to GLP-1 receptor activation.

van Bloemendaal L, Veltman DJ, ten Kulve JS, Drent ML, Barkhof F, Diamant M, IJzerman RG.

Obesity (Silver Spring). 2015 Oct;23(10):2075-82. doi: 10.1002/oby.21200. Epub 2015 Aug 31.

27.

Liraglutide Reduces CNS Activation in Response to Visual Food Cues Only After Short-term Treatment in Patients With Type 2 Diabetes.

Ten Kulve JS, Veltman DJ, van Bloemendaal L, Barkhof F, Drent ML, Diamant M, IJzerman RG.

Diabetes Care. 2016 Feb;39(2):214-21. doi: 10.2337/dc15-0772. Epub 2015 Aug 17.

PMID:
26283736
28.

Brain reward-system activation in response to anticipation and consumption of palatable food is altered by glucagon-like peptide-1 receptor activation in humans.

van Bloemendaal L, Veltman DJ, Ten Kulve JS, Groot PF, Ruhé HG, Barkhof F, Sloan JH, Diamant M, Ijzerman RG.

Diabetes Obes Metab. 2015 Sep;17(9):878-86. doi: 10.1111/dom.12506. Epub 2015 Jul 22.

PMID:
26094857
29.

GLP-1 receptor activation modulates appetite- and reward-related brain areas in humans.

van Bloemendaal L, IJzerman RG, Ten Kulve JS, Barkhof F, Konrad RJ, Drent ML, Veltman DJ, Diamant M.

Diabetes. 2014 Dec;63(12):4186-96. doi: 10.2337/db14-0849. Epub 2014 Jul 28.

30.

Ventral striatum, but not cortical volume loss, is related to cognitive dysfunction in type 1 diabetic patients with and without microangiopathy.

van Duinkerken E, Schoonheim MM, Steenwijk MD, Klein M, IJzerman RG, Moll AC, Heymans MW, Snoek FJ, Barkhof F, Diamant M.

Diabetes Care. 2014 Sep;37(9):2483-90. doi: 10.2337/dc14-0016. Epub 2014 Jun 27.

PMID:
24973436
31.

Effects of insulin detemir and NPH insulin on body weight and appetite-regulating brain regions in human type 1 diabetes: a randomized controlled trial.

van Golen LW, Veltman DJ, IJzerman RG, Deijen JB, Heijboer AC, Barkhof F, Drent ML, Diamant M.

PLoS One. 2014 Apr 16;9(4):e94483. doi: 10.1371/journal.pone.0094483. eCollection 2014.

32.

Differential impact of subclinical carotid artery disease on cerebral structure and functioning in type 1 diabetes patients with versus those without proliferative retinopathy.

van Duinkerken E, Ijzerman RG, van der Zijl NJ, Barkhof F, Pouwels PJ, Schoonheim MM, Moll AC, Boerop J, Wessels AM, Klein M, Snoek FJ, Diamant M.

Cardiovasc Diabetol. 2014 Mar 12;13:58. doi: 10.1186/1475-2840-13-58.

33.

Effects of glucagon-like peptide 1 on appetite and body weight: focus on the CNS.

van Bloemendaal L, Ten Kulve JS, la Fleur SE, Ijzerman RG, Diamant M.

J Endocrinol. 2014 Mar 7;221(1):T1-16. doi: 10.1530/JOE-13-0414. Print 2014 Apr. Review.

PMID:
24323912
34.

Proliferative retinopathy in type 1 diabetes is associated with cerebral microbleeds, which is part of generalized microangiopathy.

Woerdeman J, van Duinkerken E, Wattjes MP, Barkhof F, Snoek FJ, Moll AC, Klein M, de Boer MP, Ijzerman RG, Serné EH, Diamant M.

Diabetes Care. 2014 Apr;37(4):1165-8. doi: 10.2337/dc13-1586. Epub 2013 Dec 6.

PMID:
24319122
35.

Quantification of cerebral blood flow in healthy volunteers and type 1 diabetic patients: comparison of MRI arterial spin labeling and [(15)O]H2O positron emission tomography (PET).

van Golen LW, Kuijer JP, Huisman MC, IJzerman RG, Barkhof F, Diamant M, Lammertsma AA.

J Magn Reson Imaging. 2014 Dec;40(6):1300-9. doi: 10.1002/jmri.24484. Epub 2013 Nov 8.

PMID:
24214919
36.

Cerebral blood flow and glucose metabolism in appetite-related brain regions in type 1 diabetic patients after treatment with insulin detemir and NPH insulin: a randomized controlled crossover trial.

van Golen LW, IJzerman RG, Huisman MC, Hensbergen JF, Hoogma RP, Drent ML, Lammertsma AA, Diamant M.

Diabetes Care. 2013 Dec;36(12):4050-6. doi: 10.2337/dc13-0093. Epub 2013 Oct 15.

37.

Glucocorticoid treatment impairs microvascular function in healthy men in association with its adverse effects on glucose metabolism and blood pressure: a randomised controlled trial.

van Raalte DH, Diamant M, Ouwens DM, Ijzerman RG, Linssen MM, Guigas B, Eringa EC, Serné EH.

Diabetologia. 2013 Nov;56(11):2383-91. doi: 10.1007/s00125-013-3016-8. Epub 2013 Aug 11.

PMID:
23933953
38.

Cerebral blood flow and glucose metabolism measured with positron emission tomography are decreased in human type 1 diabetes.

van Golen LW, Huisman MC, Ijzerman RG, Hoetjes NJ, Schwarte LA, Lammertsma AA, Diamant M.

Diabetes. 2013 Aug;62(8):2898-904. doi: 10.2337/db12-1159. Epub 2013 Mar 25.

39.

Effects of induced hyperinsulinaemia with and without hyperglycaemia on measures of cardiac vagal control.

Berkelaar M, Eekhoff EM, Simonis-Bik AM, Boomsma DI, Diamant M, Ijzerman RG, Dekker JM, 't Hart LM, de Geus EJ.

Diabetologia. 2013 Jun;56(6):1436-43. doi: 10.1007/s00125-013-2848-6. Epub 2013 Feb 13.

PMID:
23404443
40.

Cerebral blood flow and glucose metabolism in healthy volunteers measured using a high-resolution PET scanner.

Huisman MC, van Golen LW, Hoetjes NJ, Greuter HN, Schober P, Ijzerman RG, Diamant M, Lammertsma AA.

EJNMMI Res. 2012 Nov 20;2(1):63. doi: 10.1186/2191-219X-2-63.

41.

Resting-state brain networks in type 1 diabetic patients with and without microangiopathy and their relation to cognitive functions and disease variables.

van Duinkerken E, Schoonheim MM, Sanz-Arigita EJ, IJzerman RG, Moll AC, Snoek FJ, Ryan CM, Klein M, Diamant M, Barkhof F.

Diabetes. 2012 Jul;61(7):1814-21. doi: 10.2337/db11-1358. Epub 2012 Mar 20.

42.

Diffusion tensor imaging in type 1 diabetes: decreased white matter integrity relates to cognitive functions.

van Duinkerken E, Schoonheim MM, Ijzerman RG, Klein M, Ryan CM, Moll AC, Snoek FJ, Barkhof F, Diamant M, Pouwels PJ.

Diabetologia. 2012 Apr;55(4):1218-20. doi: 10.1007/s00125-012-2488-2. Epub 2012 Feb 11. No abstract available.

43.

Insulin-induced capillary recruitment is impaired in both lean and obese women with PCOS.

Ketel IJ, Serné EH, Ijzerman RG, Korsen TJ, Twisk JW, Hompes PG, Smulders YM, Homburg R, Vorstermans L, Stehouwer CD, Lambalk CB.

Hum Reprod. 2011 Nov;26(11):3130-7. doi: 10.1093/humrep/der296. Epub 2011 Sep 13.

PMID:
21920943
44.

Valsartan-induced improvement in insulin sensitivity is not paralleled by changes in microvascular function in individuals with impaired glucose metabolism.

van der Zijl NJ, Serné EH, Goossens GH, Moors CC, Ijzerman RG, Blaak EE, Diamant M.

J Hypertens. 2011 Oct;29(10):1955-62. doi: 10.1097/HJH.0b013e32834a7667.

PMID:
21844821
45.

No effect of epoprostenol on right ventricular diameter in patients with acute pulmonary embolism: a randomized controlled trial.

Kooter AJ, Ijzerman RG, Kamp O, Boonstra AB, Smulders YM.

BMC Pulm Med. 2010 Mar 30;10:18. doi: 10.1186/1471-2466-10-18.

46.

Two cases of antiruthenium antibody interference in Modular free thyroxine assay.

Heijboer AC, Ijzerman RG, Bouman AA, Blankenstein MA.

Ann Clin Biochem. 2009 May;46(Pt 3):263-4. doi: 10.1258/acb.2009.008258. Epub 2009 Mar 4. No abstract available.

PMID:
19261677
47.

Incorporation of the fasting free fatty acid concentration into quantitative insulin sensitivity check index improves its association with insulin sensitivity in adults, but not in children.

Ijzerman RG, Stehouwer CD, Serné EH, Voordouw JJ, Smulders YM, Delemarre-van de Waal HA, van Weissenbruch MM.

Eur J Endocrinol. 2009 Jan;160(1):59-64. doi: 10.1530/EJE-08-0699. Epub 2008 Oct 3.

PMID:
18835976
48.

Commentary on viewpoint: the human cutaneous circulation as a model of generalized microvascular function.

Ijzerman RG, de Jongh RT, Serné EH.

J Appl Physiol (1985). 2008 Jul;105(1):378; author reply 389. doi: 10.1152/japplphysiol.90344.2008. No abstract available.

49.

Birth weight relates to salt sensitivity of blood pressure in healthy adults.

de Boer MP, Ijzerman RG, de Jongh RT, Eringa EC, Stehouwer CD, Smulders YM, Serné EH.

Hypertension. 2008 Apr;51(4):928-32. doi: 10.1161/HYPERTENSIONAHA.107.101881. Epub 2008 Feb 20.

PMID:
18287343
50.

Impaired local microvascular vasodilatory effects of insulin and reduced skin microvascular vasomotion in obese women.

de Jongh RT, Serné EH, IJzerman RG, Jørstad HT, Stehouwer CD.

Microvasc Res. 2008 Mar;75(2):256-62. Epub 2007 Aug 21.

PMID:
17920639

Supplemental Content

Loading ...
Support Center